HER2 Amplification for Colorectal Cancer Enhanced Stratification (HERACLES) was an important phase II study as it proved the concept that blockade of HER2 can be achieved by trastuzumab and lapatinib (a dual EGFR and HER2 TKI) in HER2-positive mCRC. Here, EGFR is linked to colorectal cancer.